Par Pharmaceutical Has Issued a Voluntary Nationwide Recall of One Lot of Treprostinil Injection Due to Potential for Silicone Particulates Within the Product Solution
Endo International plc announced on March 12, 2024, that one of its operating companies, Par Pharmaceutical, Inc.